580 related articles for article (PubMed ID: 25625193)
1. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
Lamb R; Ozsvari B; Lisanti CL; Tanowitz HB; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Mar; 6(7):4569-84. PubMed ID: 25625193
[TBL] [Abstract][Full Text] [Related]
2. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
[TBL] [Abstract][Full Text] [Related]
4. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy".
Fiorillo M; Verre AF; Iliut M; Peiris-Pagés M; Ozsvari B; Gandara R; Cappello AR; Sotgia F; Vijayaraghavan A; Lisanti MP
Oncotarget; 2015 Feb; 6(6):3553-62. PubMed ID: 25708684
[TBL] [Abstract][Full Text] [Related]
5. Drug therapy: Can the mitochondrial adverse effects of antibiotics be exploited to target cancer metabolism?
Killock D
Nat Rev Clin Oncol; 2015 Apr; 12(4):190. PubMed ID: 25668730
[No Abstract] [Full Text] [Related]
6. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).
Fiorillo M; Lamb R; Tanowitz HB; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Aging (Albany NY); 2016 Aug; 8(8):1593-607. PubMed ID: 27344270
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
[TBL] [Abstract][Full Text] [Related]
9. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
10. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
11. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.
Zhong Y; Li X; Yu D; Li X; Li Y; Long Y; Yuan Y; Ji Z; Zhang M; Wen JG; Nesland JM; Suo Z
Oncotarget; 2015 Nov; 6(35):37758-69. PubMed ID: 26413751
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction.
Lamb R; Harrison H; Smith DL; Townsend PA; Jackson T; Ozsvari B; Martinez-Outschoorn UE; Pestell RG; Howell A; Lisanti MP; Sotgia F
Oncotarget; 2015 Mar; 6(7):4585-601. PubMed ID: 25671304
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.
Lamb R; Fiorillo M; Chadwick A; Ozsvari B; Reeves KJ; Smith DL; Clarke RB; Howell SJ; Cappello AR; Martinez-Outschoorn UE; Peiris-Pagès M; Sotgia F; Lisanti MP
Oncotarget; 2015 Jun; 6(16):14005-25. PubMed ID: 26087309
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria: An intriguing target for killing tumour-initiating cells.
Yan B; Dong L; Neuzil J
Mitochondrion; 2016 Jan; 26():86-93. PubMed ID: 26702582
[TBL] [Abstract][Full Text] [Related]
17. Hydrogel microstructure live-cell array for multiplexed analyses of cancer stem cells, tumor heterogeneity and differential drug response at single-element resolution.
Afrimzon E; Botchkina G; Zurgil N; Shafran Y; Sobolev M; Moshkov S; Ravid-Hermesh O; Ojima I; Deutsch M
Lab Chip; 2016 Mar; 16(6):1047-62. PubMed ID: 26907542
[TBL] [Abstract][Full Text] [Related]
18. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
19. Metformin and prostate cancer stem cells: a novel therapeutic target.
Mayer MJ; Klotz LH; Venkateswaran V
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
[TBL] [Abstract][Full Text] [Related]
20. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
